NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT02892123 2024-11-27Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersJazz PharmaceuticalsPhase 1 Completed279 enrolled
NCT00403429 2016-01-14MITO-6: Capecitabine in Platinum Resistant Ovarian CancerNational Cancer Institute, NaplesPhase 2 Completed36 enrolled
NCT00004012 2013-06-24Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerMemorial Sloan Kettering Cancer CenterPhase 2 Completed